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Objective. To investigate CT morphologic and densitometric features and 18-FDG PET findings of surgically excised lung
adenocarcinomas “mixed subtype” with predominant lepidic component, appearing as solid solitary pulmonary nodules (SPNs)
on CT scan. Materials and Methods. Approval for this study was given from each local institutional review board according to its
retrospective nature. Nodules pathologically classified as lung adenocarcinoma mixed subtype with bronchioloalveolar otherwise
lepidic predominant component, in three different Italian institutions (Napoli;Varese; Parma),were retrospectively selected.Results.
22 patients were identified. The number of SPNs with smooth margins was significantly lower with respect to the number of SPNs
with spiculatedmargins (p: 0.033), radiating spiculations (p: 0.019), and notch sign (p: 0.011). Mean contrast enhancement (CE) was
53.34 HU (min 5.5 HU, max 112 HU); considering 15 HU as cut-off value, CE was positive in 20/22 cases. No significant correlation
was found between size and CE. Mean SUVmax was 2.21, ranging from 0.2 up to 7.5 units; considering 2.5 units as cut-off, SUVmax
was positive in 7/22 cases. The number of SPNs with positive CE was significantly higher than the number of SPNs with positive
SUVmax (p: 0.0005).Conclusion. CT generally helps in identifying solid SPN suspicious formalignancy but 18-FDGPETmay result
in false-negative evaluation; when 18-FDG PET findings of a solid SPN are negative even though CT morphology and CE suggest
malignancy, radiologist should consider that lepidic component may be present inside the invasive tumor, despite the absence of
ground glass.
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1. Introduction
Lung adenocarcinoma (LA) is the most common histological
subtype of lung cancer representing the leading cause of
cancer-related death in both men and women throughout
the world [1, 2]. When LA presents as a solitary pulmonary
nodule (SPN) it is often still in stage I, and the patients often
can be cured or have a long survival after proper treatment
[3]. Recent data showed that LA histomorphological growth
patterns seem to be associated with different prognosis in
terms of survival differences [4]. With this background, in
2011 the International Association for the Study of Lung
Cancer, American Thoracic Society, and European Respi-
ratory Society (IASLC/ATS/ERS) proposed an International
Multidisciplinary Lung Adenocarcinoma Classification [5].
Ever since, invasive LAs are classified by predominant pattern
after using comprehensive histologic subtyping with lepidic,
acinar, papillary, and solid patterns; micropapillary is added
as a new histologic subtype [2, 5]. Moreover, the terms
“bronchioloalveolar” (BAC) and “mixed subtype” LA are no
longer used: LAs previously classified as “mixed subtype”
with predominant nonmucinous BAC component are now
stated as “lepidic predominant adenocarcinomas” (LPAs) [5].
Lepidic component is reported to influence the appearance of
the SPN on computed tomography (CT) scan [6–10]: lepidic
growth appears hazy and nonsolid (ground-glass) while the
solid component is partly related to invasive growth of the
tumor [5, 11]. Therefore, lepidic growth is less likely to occur
in solid SPN when compared with semi-solid and ground-
glass nodules [4, 12]. Since the presence of lepidic component
is reported to determine a more favorable survival for small
solitary resected invasive LAs [6], our aim was to investigate
CT morphologic and densitometric features and 18-fluorine-
fluorodeoxyglucose (18-FDG) findings of surgically excised
LAs previously named “mixed subtype” with predominant
BACcomponent, now stated as lepidic component, appearing
as solid SPNs on CT scan.
2. Materials and Methods
2.1. Population. Approval for this study was given from each
local institutional review board according to its retrospective
nature. In a search of lung cancer pathological registry
databases of three different Italian institutions (Ospedale
Monaldi, Azienda dei Colli Napoli; Ospedale di Circolo
Fondazione Macchi, Varese; Azienda Ospedaliera Universi-
taria di Parma, Parma) 1311 surgically excised SPNs were
retrospectively identified, from January 2012 to December
2014.
Among all SPNs excised, nodules classified as LA mixed
subtype with BAC predominant component were retrospec-
tively selected. Then, for each SPN, picture archiving and
communication systems (PACS) were screened for available
preoperative multidetector CT examinations and 18-FDG
PET-CT studies.
Inclusion criteria for the study were histological diagnosis
of LA mixed subtype with predominant BAC otherwise
lepidic component, single solid nodule on CT examination
with no evidence of malignant satellite nodules and without
hilar or mediastinal lymphadenopathy, availability of a recent
(< 4 weeks) preoperative 18-FDG PET-CT study.
2.2. Imaging and Interpretation
2.2.1. CT Images Analysis. Images were acquired using 3
different 64 rows CT scanners (LightSpeed Volume CT,
GE Healthcare, United States; Toshiba Aquilion 64 system,
Toshiba Medical Systems, Otawara; Sensation 64, Siemens,
Erlangen, Germany) after having obtained patients’ informed
consent. Unenhanced CT images were acquired in spiral
mode and scans were performed at suspended maximal
inspiration after appropriate instruction of the patients to
minimize breathing artifacts. Contrast enhanced scans were
acquired in spiral mode during the portal phase after intra-
venous administration of 1-2ml/Kg body weight, limited to
150mL, of nonionic iodinated contrast medium (CM) at a
rate of 2.5-3.5mL/s, followed by a flush of saline solution at
a rate of 2.5mL/s.
All CT images were evaluated on vendors’ CT work-
stations displaying images on two monitors to view both
mediastinal (width, 400 HU; level, 40 HU) and lung (width,
1500 HU; level, -500 HU) window images. Two independent
radiologists who were unaware of the clinical 18-FDG PET
findings and blind to each other, retrospectively, evaluated all
CT examinations to select SNPs which fulfilled the above-
mentioned inclusion criteria. Any differences were resolved
by consensus; for quantitative variables, the mean value of
the two radiologists’ measurements was selected. CT images
were assessed for the appearance of each nodule to select
nodules that appeared solid, evaluating the maximum axial
size (Dmax), margins, presence of notch sign and radial
spiculations, seat of the lesion, and finally CE. LA nodules
were considered solid on CT images if nodules completely
obscured the entire lung parenchyma within them [13]. The
size of each nodule was assessed according to the longest
diameter on the transverse lung window image where the
largest nodule dimension appeared. Margins of the nodules
were distinguished as smooth, lobulated, irregular, and spic-
ulated, while an irregular indentation of the margin of the
nodule, a “concave cut”, was stated as notch [11]. Radial
spiculations were defined as lines radiating from the margins
of the nodule [14]. Moreover, the presence of fat and/or
calcifications inside the nodule and SPN localization in
lung segments were noticed. After morphological evaluation,
densitometric measurements of SPNs were obtained in both
precontrast and postcontrast phases. A region of interest
(ROI) was drawn inside each SPN along the equatorial plane,
as large as possible in order to minimize noise, but care
was taken to avoid partial volume effects and any calcified
inclusions, vessels, bronchogram, or inner necrotic areas.
To avoid interfusion of air space, the reader magnified the
image for display on the viewer and drew ROIs inside the
boundary of tumors. SPN attenuation value of enhanced
CT scan minus the baseline attenuation on unenhanced
CT scan was defined as CE considering 15 HU as cut-off
value.
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2.2.2. 18-FDG PET-CT Images Analysis. Two types of hybrid
PET-CT scannerswere used (Biograph 16; Siemens, Erlangen,
Germany; GE, Milwaukee, USA). In all cases, 18-FDG PET
acquisition was performed from feet to head 60 minutes
after intravenous administration of 18F-FDG (4.5 MBq/kg).
Emission scan bed time was 3min, resulting in a total PET
scan time of approximately 20-25min.
Hybrid 18-FDG PET-CT images were reconstructed on
each specific workstation. The referring experienced inter-
preters of each institution, who were unaware of clinical
and pathologic results, evaluated 18-FDG PET-CT images
by a semiquantitative analysis of 18-FDG uptake based on a
volume of interest to calculate the maximum standard uptake
value (SUVmax) considering 2.5 units as cut-off value.
2.3. Statistical Analysis. The variables considered for mor-
phologic analysiswere size (Dmax), type ofmargins, presence
of notch sign, and radial spiculations; densitometric evalua-
tion was based on CE value in portal phase while metabolic
assessment concerned with SUVmax.
Student T-test was used for the comparison of two
means applied to small populations samples (i.e., mean
Dmax, margins, mean CE, and mean SUVmax). Pearson
correlation coefficient was used to measure the strength of
a linear association between two variables (i.e., maximum
diameter, types of margins, CE, and SUVmax). McNemar’s
exact test was used to compare paired proportions (i.e., the
percentage of SPNs with positive CE and the percentage
of SPNs with positive SUV, the percentage of SPNs with
spiculated margins, and the percentage of SPNs with smooth
margins).
Continuous and categorical variables were analyzed (Stu-
dent T-test, Pearson correlation coefficient, and McNemar’s
exact test) with Matlab statistical toolbox version 2008
(MathWorks, Natick, MA, USA) for Windows at 32 bit. A p-
value < 0.05 was considered significant.
3. Results and Discussion
3.1. Results. 22 patients (17 males and 5 females) with a mean
age of 71.09±9.16 years were finally identified, who fulfilled
the inclusion criteria. CTmorpho-densitometric features and
SUVmax values of the 22 SPNs evaluated are reported in
Table 1.
Main significant results of imaging analysis are summa-
rized in Table 2, expressed as the mean value and standard
deviation (SD) for continuous variables and as percentage for
categorical variables.
Among the 22 SPNs selected, mean maximum diameter
was 15.45mm (range 7–26mm). Most (9/22) of SPNs pre-
sented spiculated margins, while margins were lobulated in
6/22 cases, irregular in 6/22 cases, and smooth in 2/22 cases.
The notch sign was present in 10 nodules and radial spicules
were observed in 9 cases.
The number of SPNs with smooth margins were signifi-
cantly lower with respect to the number of SPNs with spicu-
lated margins (p: 0.033), radiating spiculations (p: 0.019), and
notch sign (p: 0.011).
All solid nodules did not contain any calcifications or fat.
SPNs were peripherally located as follows: 3 in the apical
segment of right upper lobe, 5 in the apico-dorsal segment of
the left upper lobe, 3 in the dorsal segment of the right upper
lobe, 1 in the middle lobe, 1 in the apical segment of the right
lower lobe, 3 in the apical segment of the left lower lobe, 1 in
the lingula, and 5 in the posterior basal segment of the right
lower lobe.
Mean CE was 53.34 HU (min 5.5 HU, max 112 HU);
considering 15 HU as cut-off value, CE was positive in 20/22
cases. No significant correlation was found between size and
CE.
Mean SUVmax was 2.21, ranging from 0.2 up to 7.5 units;
considering 2.5 units as cut-off, SUVmax was positive in 7/22
cases.
The number of SPNs with positive CE was significantly
higher than the number of SPNs with positive SUVmax (p:
0.0005).
SUVmax showed statistically significant correlations with
Dmax (R:0.501) and with lobulated margins (R:0.455); in
particular, SPNs with positive SUVmax presented diameters
statistically significant (p: 0.038) greater than SPNs with
negative SUVmax.
3.2. Discussion. SPNs are frequently encountered on chest
imaging and represent an important diagnostic challenge
because their radiologic characterization is very complex
[15, 16].The evaluation of morphologic features is recognized
to be a useful tool to assess the likelihood of malignancy,
although there is a considerable overlap between benign and
malignant morphology in many cases [17, 18]. Moreover,
despite CT technological advances, determining the etiol-
ogy of a lung nodule without invasive approach remains
problematic and the current “gold standard” for diagnosing
pulmonary nodules still remains pathology, requiring sam-
ples obtained either surgically or by percutaneous biopsy
[18–20]. The employment of 18-FDG PET as a diagnostic
tool could reduce the number of unnecessary biopsies or
thoracotomies on benign SPNs; however it could also show
false negative results for lesions smaller than 2 cm and for
well-differentiated invasive LAs (i.e., with lepidic component)
having low metabolic rate [12, 18].
To predict LA histological subtype and then patient prog-
nosis by using imaging tools despite invasive pathological
scoring system may be very attractive. In this context, we
aimed to investigate if the presence of lepidic component
inside LAs appearing as solid SPNs on CT images could affect
their morphological, CE, and SUVmax features.
3.2.1. CT Morpho-Densitometric Features. In our study were
included LAs with histopathologically proven predominant
lepidic component which appeared as solid SPNs on CT
images.
It has been well demonstrated that CT attenuation of
lung lesions closely reflects the proportion of histological
components; the invasive growth characteristically appears
solid and the noninvasive lepidic growth is hazy and nonsolid
[9, 11]. According to this, a recent study reported that lepidic
growth is significantly less likely to occur in solid tumors as
determined by CT (9,6%) when compared with semi-solid
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Table 1: Study sample.The table shows the morphologic features, CE (contrast enhancement) and SUVmax of all SPNs grouped according to
margin type; +: presence; -: absence.
MARGINS NOTCH SUNBURST DIAMETER (MM) CE (HU) SUVmax
SPICULATED + - 8,00 88 1,20
+ - 10,00 97 0,20
- + 10,00 6 1,60
- + 12,00 30 0,80
+ - 13,00 48 0,40
- + 18,00 94 0,8
+ - 19,00 88 0,40
+ - 22,00 24 1,70
+ + 26,00 23 7,5
IRREGULAR - - 7,00 69 2,4
- + 12,00 112 2,60
+ - 18,00 92 1,5
+ - 24,00 39 5,6
- + 24,00 20 0,60
LOBULATED - - 9,00 5,5 2,6
- - 13,00 67 2,5
- - 13,00 21 1,50
+ + 16,00 67 0,20
- - 20,00 23 5,3
- + 22,00 57 7,14
SMOOTH - - 11,00 59 1,80
+ + 13,00 44 0,30
Table 2: Imaging parameters and significant statistical tests. The table shows the main results of imaging analysis expressed as the mean value
and standard deviation (SD) for continuous variables and as percentage for categorical variables. For statistical tests, a p-value < 0.05 was
considered significant.
Parameters Mean ± SD Correlation
Maximum diameter (Dmax) 15.45 ± 2.58 Dmax / SUVmax: R = 0.501
CE 53.34 ± 31.49 SUVmax/Lobulated: R = 0.455
SUVmax 2.21 ± 2.15
Morphologic parameters % Hypothesis p-value
Spiculated margins (SpM) 40.91 Spicules (40.91%) vs. SmM (9.09%) 0.0195 (M)
Lobulated margins (LM) 27.27 SpM (40.91%) vs. SmM (9.09%) 0.0327 (M)
Irregular margins (IM) 27.27 Notch (45.45%) vs. SmM (9.09%) 0.0107 (M)
Smooth margins (SmM) 9.09 CE (90.91%) vs. SUVmax (31.82%) 4.9⋅10−4 (M)
Notch 45.45 CE (90.91%) vs. SpM (40.91%) 1.7⋅10−3 (M)
Spicules 40.91 CE (90.91%) vs. LM (27.27%) 2.6⋅10−4 (M)
Positive CE (≥ 15 HU) CE (90.91%) vs. IM (27.27%) 6.0⋅10−5 (M)
CE + 90.91 CE (90.91%) vs. SmM (9.09%) 4.0⋅10−6 (M)
Positive SUVmax (≥ 2.5) CE (90.91%) vs. Notch (45.45%) 9.8⋅10−4 (M)
SUVmax + 31.82 CE (90.91%) vs. Spicules (40.91%) 1.7⋅10−3 (M)
Parameters Mean ± SD Hypothesis p-value
Dmax (SUV ≥ 2.5) 18.86 ± 5.62 Dmax (SUV ≥ 2.5) vs. Dmax (SUV < 2.5) 0.0384 (T)
Dmax (SUV < 2.5) 14.27 ± 4.88
T: T-Student test; R: Pearson’s linear correlation coefficient; M: McNemar’s exact test.
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(17,7%) and ground-glass opacity (67,5%) tumors [4]. How-
ever, a solid appearance on CT can reflect a collapse of the
alveolar wall, fibrosis, other than proliferation of invasive
tumor cells [21, 22]. These considerations account for the
small number of solid SPNs of LA with predominant lepidic
component we found; however, the number of our patients is
of the same order of size of LPAs described in several reports
[2–4, 23, 24]. Although it has been reported that semi-solid
or nonsolid nodules are more likely to be malignant than
solid ones [13, 16], in our study all solid SPNs were lung
cancer. An important aspect of LAs is that, for SPNs, the
size of the invasive component is an independent predictor
of survival [11]. Furthermore, disease-free survival correlates
with solid tumor size but not with “whole tumor size” that
includes a nonsolid (ground-glass) component [10, 11]. So,
the solid area seems to be a better marker for prognosis
prediction compared with the whole nodule diameter [25].
In our study, being all nodules solid on CT images, solid
diameter corresponded to the whole nodule diameter. Lesion
size is a recognized valid predictor of malignancy: nodules
with diameter less than 5mm, 5 to 10mm, and greater than
2 cm, are associated with malignancy rates of less than 1%, 6-
28%, and 64-82%, respectively [20]. In our study, none of the
SPNs had diameter less than 5mm,while 5NPSs were greater
than 20mm.
Although it is not possible to differentiate various his-
tological subtypes of LA distinctively at CT according to
their appearances [26], it has been reported that margin
configuration is associated with distinct histopathological LA
growth patterns [4]. Recently, LPAs have been reported to
have no predominant margin pattern and this assumption
is in agreement with our findings: margins of our SPNs
ranged from smooth to spiculated. Lederlin et al. observed
that lepidic growth was associated with mixed, irregular,
margins (27,4%) more frequently than spiculated (10.4%) or
smooth ones (5.4%) [4]. As our study, smooth margins were
significantly the less frequent margin type observed (9.09%)
also, while spiculated margins, although they represented
the majority of cases (40.91%), did not reach a significant
statistical predominance. SPNs with irregular, spiculated
margins or lobulated contours, are typically associated with
malignancy [18]. Smooth margins, however, are not diagnos-
tic of benignity and do not exclude malignity, as up to one-
third of malignant nodules have well-defined margins [17].
Edge characteristics indicative of malignancy and correlated
with a desmoplastic response in the nodule include also
the presence of spicules radiating from the nodule, often
described as “sunburst” or “corona radiata” appearance [27].
We noticed sunburst in 9/22 SPNs, while 10/22 SPNs showed
the “notch sign”: it is reported that notching or umbilication
of any portion of the border of a spherical nodule should
cause concern for malignancy [28]. In a recent report, notch
sign in small (<20mm) solid-density LA appeared to be
a somewhat unfavorable prognostic sign [29]. This notch
pattern probably could correspond to the irregular edge of
the invasive component shown at the histology [11, 30].
In our study, SPNs did not show a prevalent involvement
of a single lung segment but were all located in peripheral
parenchyma. However, SPN location alone cannot be used as
an independent predictor of malignancy and AC histological
subtype [16].
Although several studies reported some associations
between tumor CE and grading, intratumoral fibrosis, and
angiogenic activity [31–33], to the best of our knowledge,
the correlation between CE and AC histologic subtypes
according to IASLC/ATS/ERS classification has not yet been
investigated. Contrast-enhanced CT improves accuracy of
benign versus malignant differentiation of SPNs [19]. Nodule
behavior after contrast material administration is sensitive
but not specific for malignancy; however nodule enhance-
ment of less than 15 HU is strongly indicative of benignity
[16, 18, 34–37]. Higher accuracy is reported for dynamic
enhancement evaluation on helical CT (HDCT), analyzing
combined wash-in (WI) and washout (WO) characteristics
[18, 38]. In our study, given the retrospective assessment of
CT exams, we considered only one scan acquired in portal
phase after contrast medium administration. In this way,
we observed a CE < 15 UH in 2 patients only. Typically,
peak nodular enhancement is appreciated with a multiphase
dynamic CT scan among 40 to 180 s after IV contrast
medium injection [39], then we did not obtain the peak
of enhancement, but only a single value of attenuation to
compare with the baseline one. This approach could explain
why we had 2 CE false negative cases: with more CT
acquisitions at different times probably we could observe
these nodules enhance more than 15 HU. However, also if
CE less than 15 HU indicates benignity [35], these nodules
showed other characteristics of suspicious malignancy such
as lobulated or spiculated margins and/or SUVmax > 2,5
(Table 1). According to this, it has been reported that the
evaluation of solid SPNs by combined analysis of CE values
and morphologic features through CT scans can provide
92% sensitivity and 79% specificity [39]. We did not find
a significant correlation between CE and size; however
positive CE was statistically significant more frequent than
morphologic features of malignancy (spiculated or lobulated
margins, sunburst and notch sign) (Table 2).
3.2.2. 18-FDG PET-CT Metabolic Findings. 18-FDG PET-CT
is an essential tool in current lung cancer diagnostic practice:
it is not only useful for staging, evaluating therapeutic effects,
but it is also useful for differentiating localized pulmonary
lesions [10, 12, 40]. SUVmax higher than 2.5 yields likelihood
for malignancy [16], although certain neoplasms, such as
carcinoid, formerly named BAC and well-differentiated LAs,
can have a lowmetabolic rate that may result in false-negative
examinations [18, 41]. Indeed, SUVmax is strongly correlated
with pathologic score [2, 10, 42]. It has been described that
18-FDG PET is falsely negative in around 50% of patients
with BAC, or adenocarcinoma in situ (AIS) [18]. Even though
18-FDG PET scan findings may be negative, these nonsolid
histological type cancers can generally be recognized based
on ground-glass findings at CT [12, 14]. However, in clinical
practice, lung cancers that do not show ground-glass opacity
at CT can also show false-negative 18-FDG PET findings,
as in our study [12]. Furthermore, besides histopathological
subtype, another primary factor influencing 18-FDG PET
findings is the lesion size [12, 43]; this is in agreement with
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(a) (b) (c)
(d)
Figure 1: CT (a, b) and 18-FDG PET-CT (c, d) images of a lung adenocarcinoma with lepidic predominant component appearing as a solid
nodule with smooth margins (a), showing intense CE (59 HU) despite low SUVmax (1.8).
our results that showed a statistically significant (p=0.0155)
correlation between lesion size and SUVmax (R=0.501).
Negative 18-FDG PET results for nodules smaller than
1 cm, particularly <7mm, do not confidently exclude malig-
nancy [16, 18, 44]. In our study, all SPNs were ≥ 7mm, and
SUVmax < 2.5 was observed in 15 cases (68,18%) with a mean
Dmax of 14.27mm (Table 2).
The remaining 7 SPNs presented a SUVmax ≥ 2.5 and
most (4/7) of them showed lobulated margins. Both SUVmax
≥ 2.5 and lobulated margins are typically associated with
malignancy [16, 18] and this could explain the correlation we
found between these two features (R: 0.455).
Mimae et al. proposed that tumor size ≤ 18mm and
SUVmax ≤ 3.2 indicate a low grade malignant tumor and can
histologically predict the presence of lepidic component [45].
According to this, in our study sample most (18/22) of SPNs
showed size ≤18mm and SUVmax ≤ 3.2.
Considering SPNs with SUVmax <2.5, almost all of them
(14/15) presented irregular/spiculated margins and/or sun-
burst, morphologic findings that suggested their malignancy
(Table 1). Only 1 nodule with negative SUVmax had smooth
margins, but it presented also CE > 15 HU (Figure 1). Then,
beyond morphology, CE was positive (≥ 15 HU) in 93.3%
of 18-FDG PET false negative SPNs (Figures 2 and 3). Only
1/15 SPN (diameter 10mm) presented CE <15 HU; however
spiculated margins and sunburst were shown. So, combined
analysis of CT morphology and CE allowed us to state all
SPNs as malignant lesion while low SUVmax oriented in the
majority (68.18%) of cases for well-differentiated cancer.
The results of our investigation are consistent with
recent studies which report that while high SUV correlates
with high-grade histology (solid and micropapillary), low
SUVmax correlates with low-grade histology (adenocarci-
noma in situ, minimally invasive adenocarcinoma, and LPA)
in the IASLC/ATS/ERS classification, representing also a
prognostic element for the stratification of patients in Stage
I LA [46, 47].
3.2.3. Limits. This study has several limits mainly due to its
retrospective design. CT exam technique was not standard-
ized and histological assessment considered only the predom-
inant histologic pattern without semiquantitative assessment
of the percentages of the various histologic components
proposed by IASLC/ATS/ERS classification. Then, other less
represented patterns could have variably influenced CT and
18-FDG PET-CT findings; however this is a limit of the
IASLC/ATS/ERS classification and further study is required
to evaluate howminor pattern can influence imaging findings
and clinical outcome. Neither a survival analysis nor a
prognostic evaluation was performed. Furthermore, because
some findings of our study had only small numbers of
individuals, we cannot make a definite conclusion because of
the small sample size and it is likely that some associations
were driven by small numbers in the distribution of the
parameters evaluated.
4. Conclusions
LA with lepidic component are rarely encountered as solid
SPNs on CT scan; they consist of a mixture of inva-
sive component together with noninvasive lepidic growth
which determines a wide spectrum of CT morphological
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(a) (b) (c)
Figure 2: CT (a, b) and 18-FDG PET-CT (c) images of a 18-FDG PET false negative lung adenocarcinoma with lepidic predominant
component; the solid nodule presented spiculated margins and notch sign (a), intense CE (88 HU) (b) despite low SUVmax (1.20) at 18-
FDG PET examination (c).
(a) (b) (c)
(d) (e) (f)
Figure 3: CT (a-d) and 18-FDG PET-CT (e, f) images of a 18-FDG PET false negative lung adenocarcinoma with lepidic predominant
component; the solid nodule presented spiculated margins and notch sign (a and b, lung window), intense CE (97 HU) (c, mediastinal
window) despite very low SUVmax (0.2) at 18-FDG PET examination (e, f); 1 year before the same nodule appeared as a ground-glass opacity
on CT scan (d).
features, CE behavior, and SUVmax values. CT generally
helps in identifying solid SPN suspicious for malignancy
but 18-FDG PET may result in false-negative evaluation.
Therefore, when 18-FDG PET findings of a solid SPN are
negative even though CT morphology and CE suggest
malignancy, radiologist should consider that lepidic compo-
nent may be present inside the invasive tumor, despite the
absence of ground glass, determining its low metabolic rate
[12].
Data Availability
The imaging analysis data used to support the findings of this
study are included within the article.
8 BioMed Research International
Ethical Approval
Approval for this studywas given fromeach local institutional
review boards according to its retrospective nature.
Consent
Informed consent was obtained from all patients before
diagnostic examinations.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Authors’ Contributions
Alfonso Reginelli and Raffaella Capasso contributed equally
to this work and share the first authorship.
References
[1] P. P. T. E. S. Torres, J. Capobianco, M. E. M. Ju´nior, and G.
S. P. Meirelles, “Aspects of bronchioloalveolar carcinoma and
of adenocarcinoma with a bronchioloalveolar component: CT
findings,” Jornal Brasileiro de Pneumologia, vol. 38, no. 2, pp.
218–225, 2012.
[2] H. Y. Lee, J. Y. Jeong, K. S. Lee et al., “Solitary pulmonary
nodular lung adenocarcinoma: Correlation of histopathologic
scoring and patient survival with imaging biomarkers,” Radiol-
ogy, vol. 264, no. 3, pp. 884–893, 2012.
[3] H.-D. Hu, M.-Y. Wan, C.-H. Xu et al., “Histological subtypes
of solitary pulmonary nodules of adenocarcinoma and their
clinical relevance,” Journal of Thoracic Disease, vol. 5, no. 6, pp.
841–846, 2013.
[4] M. Lederlin, M. Puderbach, T. Muley et al., “Correlation of
radio-and histomorphological pattern of pulmonary adenocar-
cinoma,” European Respiratory Journal, vol. 41, no. 4, pp. 943–
951, 2013.
[5] W. D. Travis, E. Brambilla, M. Noguchi, A. G. Nicholson,
K. Geisinger, Y. Yatabe et al., “International association for
the study of lung cancer/american thoracic society/european
respiratory society internationalmultidisciplinary classification
of lung adenocarcinoma,” Journal of Thoracic Oncology, vol. 6,
no. 2, pp. 244-85, 2011.
[6] A. C. Borczuk, F. Qian, A. Kazeros et al., “Invasive size is an
independent predictor of survival in pulmonary adenocarci-
noma,” The American Journal of Surgical Pathology, vol. 33, no.
3, pp. 462–469, 2009.
[7] M. Vazquez, D. Carter, E. Brambilla et al., “Solitary andmultiple
resected adenocarcinomas after CT screening for lung cancer:
Histopathologic features and their prognostic implications,”
Lung Cancer, vol. 64, no. 2, pp. 148–154, 2009.
[8] Y. Takahashi, G. Ishii, K. Aokage, T. Hishida, J. Yoshida, and K.
Nagai, “Distinctive histopathological features of lepidic growth
predominant node-negative adenocarcinomas 3-5cm in size,”
Lung Cancer, vol. 79, no. 2, pp. 118–124, 2013.
[9] D. P. Naidich, A. A. Bankier, H. MacMahon et al., “Recommen-
dations for the management of subsolid pulmonary nodules
detected at CT: A statement from the Fleischner Society,”
Radiology, vol. 266, no. 1, pp. 304–317, 2013.
[10] Y. Tsutani, Y. Miyata, T. Yamanaka et al., “Solid tumors versus
mixed tumors with a ground-glass opacity component in
patientswith clinical stage IA lung adenocarcinoma: Prognostic
comparison using high-resolution computed tomography find-
ings,” The Journal of Thoracic and Cardiovascular Surgery, vol.
146, no. 1, pp. 17–23, 2013.
[11] J. H. M. Austin, K. Garg, D. Aberle et al., “Radiologic implica-
tions of the 2011 classification of adenocarcinoma of the lung,”
Radiology, vol. 266, no. 1, pp. 62–71, 2013.
[12] S. Iwano, S. Ito, K. Tsuchiya, K. Kato, and S. Naganawa, “What
causes false-negative PET findings for solid-type lung cancer?”
Lung Cancer, vol. 79, no. 2, pp. 132–136, 2013.
[13] C. I. Henschke, D. F. Yankelevitz, R. Mirtcheva,G.McGuinness,
D. McCauley, and O. S. Miettinen, “CT screening for lung
cancer: Frequency and significance of part-solid and nonsolid
nodules,” American Journal of Roentgenology, vol. 178, no. 5, pp.
1053–1057, 2002.
[14] H. Wang, M. B. Schabath, Y. Liu et al., “Semiquantitative
computed tomography characteristics for lung adenocarcinoma
and their association with lung cancer survival,” Clinical Lung
Cancer, vol. 16, no. 6, pp. e141–e163, 2015.
[15] V. K. Patel, S. K. Naik, D. P. Naidich et al., “A practical
algorithmic approach to the diagnosis and management of
solitary pulmonary nodules: Part 1: Radiologic characteristics
and imaging modalities,” CHEST, vol. 143, no. 3, pp. 825–839,
2013.
[16] H. T. Winer-Muram, “The solitary pulmonary nodule,” Radiol-
ogy, vol. 239, no. 1, pp. 34–49, 2006.
[17] C. A. Yi, K. S. Lee, and B. T. Kim, “Tissue characterization
of solitary pulmonary nodule: comparative study between
helical dynamic CT and integrated PET/CT,” Journal of Nuclear
Medicine, vol. 47, no. 3, pp. 443-50, Mar 2006.
[18] Y. T. Sim and F. W. Poon, “Imaging of solitary pulmonary
nodulea clinical review,” Quantitative Imaging in Medicine and
Surgery, vol. 3, no. 6, pp. 316–326, 2013.
[19] C. I. Henschke, D. F. Yankelevitz, A. P. Reeves, and M. D.
Cham, “Image analysis of small pulmonary nodules identified
by computed tomography,”Mount Sinai Journal of Medicine: A
Journal of Translational and Personalized Medicine, vol. 78, no.
6, pp. 882–893, 2011.
[20] R. Capasso, R. Nizzoli, M. Tiseo et al., “Extra-pleuric coax-
ial system for CT-guided percutaneous fine-needle aspiration
biopsy (FNAB) of small (≤20 mm) lung nodules: a novel
technique using multiplanar reconstruction (MPR) images,”
Medical Oncology, vol. 34, no. 2, 2017.
[21] Y. Kudo, J. Matsubayashi, H. Saji et al., “Association between
high-resolution computed tomography findings and the
IASLC/ATS/ERS classification of small lung adenocarcinomas
in Japanese patients,” Lung Cancer, vol. 90, no. 1, pp. 47–54,
2015.
[22] T. Hashizume, K. Yamada, N. Okamoto et al., “Prognostic
significance of thin-sectionCT scanfindings in small-sized lung
adenocarcinoma,” CHEST, vol. 133, no. 2, pp. 441–447, 2008.
[23] M. M. Wahidi, J. A. Govert, R. K. Goudar, M. K. Gould, D. C.
McCrory, andAmericanCollege of Chest Physicians, “Evidence
for the treatment of patientswith pulmonary nodules: when is it
lung cancer? ACCP evidence-based clinical practice guidelines
(2nd edition),” CHEST, vol. 132, supplement 3, pp. 94S–107S,
2007.
[24] H. N. Urer, C. I. Kocaturk,M. Z. Gunluoglu et al., “Relationship
between lung adenocarcinoma histological subtype and patient
BioMed Research International 9
prognosis,” Annals of Thoracic and Cardiovascular Surgery, vol.
20, no. 1, pp. 12–18, 2014.
[25] A. Yoshizawa, N. Motoi, G. J. Riely et al., “Impact of pro-
posed IASLC/ATS/ERS classification of lung adenocarcinoma:
Prognostic subgroups and implications for further revision of
staging based on analysis of 514 stage i cases,”Modern Pathology,
vol. 24, no. 5, pp. 653–664, 2011.
[26] H. Matsuguma, I. Oki, R. Nakahara et al., “Comparison of three
measurements on computed tomography for the prediction of
less invasiveness in patients with clinical stage i non-small cell
lung cancer,”The Annals of Thoracic Surgery, vol. 95, no. 6, pp.
1878–1884, 2013.
[27] T. Aoki, Y. Tomoda, H. Watanabe et al., “Peripheral lung
adenocarcinoma: Correlation of thin-section CT findings with
histologic prognostic factors and survival,” Radiology, vol. 220,
no. 3, pp. 803–809, 2001.
[28] C. V. Zwirewich, S. Vedal, R. R. Miller, and N. L. Mu¨ller, “Soli-
tary pulmonary nodule: high-resolution CT and radiologic-
pathologic correlation,” Radiology, vol. 179, no. 2, pp. 469–476,
1991.
[29] D. G. Jain, “Cancer in the solitary pulmonary nodule,” JIACM,
vol. 13, no. 2, pp. 116–126, 2012.
[30] M. Ikehara, H. Saito, T. Kondo et al., “Comparison of thin-
section CT and pathological findings in small solid-density
type pulmonary adenocarcinoma: Prognostic factors from CT
findings,” European Journal of Radiology, vol. 81, no. 1, pp. 189–
194, 2012.
[31] T. Honda, T. Kondo, S. Murakami et al., “Radiographic and
pathological analysis of small lung adenocarcinoma using the
new IASLC classification,” Clinical Radiology, vol. 68, no. 1, pp.
e21–e26, 2013.
[32] S. Cappabianca, A. Porto, M. Petrillo et al., “Preliminary study
on the correlation between grading and histology of solitary
pulmonary nodules and contrast enhancement and [18F] flu-
orodeoxyglucose standardised uptake value after evaluation
by dynamic multiphase CT and PET/CT,” Journal of Clinical
Pathology, vol. 64, no. 2, pp. 114–119, 2011.
[33] S. Iwano, W. Koike, K. Matsuo et al., “Correlation between
dynamic CT findings and pathological prognostic factors of
small lung adenocarcinoma,” Cancer Imaging, vol. 12, no. 1, pp.
187–193, 2012.
[34] S. J. Swensen, R. L. Morin, B. A. Schueler et al., “Solitary pul-
monary nodule: CT evaluation of enhancement with iodinated
contrast material - A preliminary report,” Radiology, vol. 182,
no. 2, pp. 343–347, 1992.
[35] S. J. Swensen, R.W.Viggiano,D. E.Midthun et al., “Lung nodule
enhancement at CT: Multicenter study,” Radiology, vol. 214, no.
1, pp. 73–80, 2000.
[36] X.-D. Ye, J.-D. Ye, Z. Yuan, W.-T. Li, and X.-S. Xiao, “Dynamic
CT of solitary pulmonary nodules: Comparison of contrast
medium distribution characteristic of malignant and benign
lesions,” Clinical and Translational Oncology, vol. 16, no. 1, pp.
49–56, 2014.
[37] A. Reginelli, C. Rossi, R. Capasso, F. Urraro, L. Cagini, V.
Di Crescenzo et al., “Evaluation with multislice CT of the
hilar pulmonary nodules for probable infiltration of vascular-
bronchial structures,”Recenti Progressi inMedicina, vol. 104, no.
7-8, pp. 403–405, 2013.
[38] S. Cappabianca, R. Capasso, M. Cirillo, M. Santagata, G.
Tartaro, and G. Colella, “Dynamic evaluation of benign neo-
plasm of parotid glands with multidetector row CT,” Minerva
stomatologica, vol. 62, no. 4, pp. 95–106, 2013.
[39] K. S. Lee, C. A. Yi, S. Y. Jeong et al., “Solid or partly solid soli-
tary pulmonary nodules: Their characterization using contrast
wash-in and morphologic features at helical CT,” CHEST, vol.
131, no. 5, pp. 1516–1525, 2007.
[40] J. W. Fletcher, S. M. Kymes, M. Gould et al., “A comparison
of the diagnostic accuracy of 18F-FDG PET and CT in the
characterization of solitary pulmonary nodules,” Journal of
Nuclear Medicine, vol. 49, no. 2, pp. 179–185, 2008.
[41] G. Rubini, S. Cappabianca, C. Altini et al., “Current clinical
use of 18FDG-PET/CT in patients with thoracic and systemic
sarcoidosis,” La Radiologia Medica, vol. 119, no. 1, pp. 64–74,
2014.
[42] H. Domen, Y. Hida, S. Okamoto et al., “Histopathologic char-
acterization of lung adenocarcinoma in relation to fluorine-18-
fluorodeoxyglucose uptake on positron emission tomography,”
Japanese Journal of Clinical Oncology, vol. 43, no. 9, Article ID
hyt100, pp. 874–882, 2013.
[43] L. Brunese, B. Greco, F. R. Setola et al., “Non-small cell lung
cancer evaluated with quantitative contrast-enhanced CT and
PET-CT: net enhancement and standardized uptake values are
related to tumour size and histology,”Medical Science Monitor,
vol. 19, no. 1, pp. 95–101, 2013.
[44] G. J. Herder, R. P. Golding, O. S. Hoekstra et al., “The perfor-
mance of 18F-fluorodeoxyglucose positron emission tomogra-
phy in small solitary pulmonary nodules,” European Journal of
NuclearMedicine andMolecular Imaging, vol. 31, no. 9, pp. 1231–
1236, 2004.
[45] T. Mimae, Y. Miyata, T. Mimura et al., “Radiologic findings
to predict low-grade malignant tumour among clinical T1bN0
lung adenocarcinomas: Lessons from histological subtypes,”
Japanese Journal of Clinical Oncology, vol. 45, no. 8, pp. 767–773,
2015.
[46] K. Kadota, C. Colovos, K. Suzuki et al., “FDG-PET SUVmax
combined with IASLC/ATS/ERS histologic classification
improves the prognostic stratification of patients with stage I
lung adenocarcinoma,” Annals of Surgical Oncology, vol. 19, no.
11, pp. 3598–3605, 2012.
[47] D. Morimoto, S. Takashima, N. Sakashita et al., “Differentiation
of lung neoplasmswith lepidic growth and goodprognosis from
thosewith poor prognosis using computer-aided 3D volumetric
CT analysis and FDG-PET,” Acta Radiologica, vol. 55, no. 5, pp.
563–569, 2014.
Stem Cells 
International
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
MEDIATORS
INFLAMMATION
of
Endocrinology
International Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Disease Markers
Hindawi
www.hindawi.com Volume 2018
BioMed 
Research International
Oncology
Journal of
Hindawi
www.hindawi.com Volume 2013
Hindawi
www.hindawi.com Volume 2018
Oxidative Medicine and 
Cellular Longevity
Hindawi
www.hindawi.com Volume 2018
PPAR Research
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2013www.hindawi.com
The Scientific 
World Journal
8
Immunology Research
Hindawi
www.hindawi.com Volume 2018
Journal of
Obesity
Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
 Computational and  
Mathematical Methods 
in Medicine
Hindawi
www.hindawi.com Volume 2018
Behavioural 
Neurology
Ophthalmology
Journal of
Hindawi
www.hindawi.com Volume 2018
Diabetes Research
Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Research and Treatment
AIDS
Hindawi
www.hindawi.com Volume 2018
Gastroenterology 
Research and Practice
Hindawi
www.hindawi.com Volume 2018
Parkinson’s 
Disease
Evidence-Based 
Complementary and
Alternative Medicine
Volume 2018
Hindawi
www.hindawi.com
Submit your manuscripts at
www.hindawi.com
